MONTREAL — Cannara Biotech Inc., a vertically integrated producer of cannabis and derivative products, appointed Justin Cohen to its board of directors as an independent director. Cohen will also serve as a member of the Audit Committee.
Cohen is a seasoned executive with a track record of driving transformational growth and providing valuable leadership in brand development, sales and marketing. As Chief Marketing and Chief Commercial Officer at Psycho Bunny, he spearheaded the brand’s evolution from a niche player to a global powerhouse. Under his leadership, revenues increased tenfold over three years, driven by strategic retail expansion, digital acceleration, and brand reinvention.
Prior to Psycho Bunny, Cohen led direct-to-consumer and e-commerce strategy at Keurig Dr Pepper, expanding its digital footprint and scaling revenue across online and omnichannel platforms. He has also held leadership roles at Google, ALDO Group, and Sony Music, where he guided brands through digital transformation and new growth opportunities.
Currently, as a senior executive at Cosmetic Physician Partners, Cohen oversees integrated marketing across a portfolio of over 55 clinics in the United States, ensuring scalable and sustainable expansion. In addition to his corporate leadership, he serves on the board of Dose Juice, advising on commercial strategy, market expansion, and operational efficiency. Mr. Cohen holds degrees in Marketing & Advertising, an MBA, and a master’s in behavioral science from the London School of Economics.
“We are thrilled to welcome Justin to our Board,” said Zohar Krivorot, CEO of Cannara. “His expertise in brand building, digital transformation, and consumer engagement aligns perfectly with Cannara’s vision to execute our strategy of positioning our three flagship brands – Tribal, Nugz, and Orchid CBD – as Canada’s leading cannabis brands. His strategic leadership will be invaluable as we scale our operations and expand our brand equity and market presence in Canada.”
“I am honored to join Cannara’s Board of Directors at such an exciting time,” said Cohen. “Cannara has established itself as a leader in the cannabis industry with a strong commitment to quality, innovation, and accessibility. I look forward to contributing my experience in brand strategy and digital transformation to support Cannara’s continued success and expansion.”
About Cannara Biotech
Cannara Biotech Inc is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price.
